Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q50126958 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010723.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q50126958 | ||
| 024 | ‡a 0000-0001-6500-4107 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q50126958 | ||
| 100 | 0 | ‡a James J La Clair ‡9 ast ‡9 es ‡9 sl | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a James J La Clair ‡c researcher ‡9 en | |
| 400 | 0 | ‡a James J La Clair ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's A Challenging Pie to Splice: Drugging the Spliceosome. | ||
| 670 | ‡a Author's Advance of Seriniquinone Analogues as Melanoma Agents | ||
| 670 | ‡a Author's Color-Coded Super-Resolution Small-Molecule Imaging | ||
| 670 | ‡a Author's Covalent modification of biological targets with natural products through Paal-Knorr pyrrole formation. | ||
| 670 | ‡a Author's Encoding matter with regiospecific 12C/13C isotopic labels | ||
| 670 | ‡a Author's Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline | ||
| 670 | ‡a Author's Fluorescent Mechanism-Based Probe for Aerobic Flavin-Dependent Enzyme Activity | ||
| 670 | ‡a Author's Future Directions of Marine Myxobacterial Natural Product Discovery Inferred from Metagenomics | ||
| 670 | ‡a Author's Metabolic and Biosynthetic Diversity in Marine Myxobacteria | ||
| 670 | ‡a Author's Ritterostatin GN 1N, a Cephalostatin-Ritterazine Bis-steroidal Pyrazine Hybrid, Selectively Targets GRP78. | ||
| 670 | ‡a Author's Searching for Small Molecules with an Atomic Sort | ||
| 670 | ‡a Author's Tailoring chemoenzymatic oxidation via in situ peracids | ||
| 670 | ‡a Author's Traceless Staudinger ligation enabled parallel synthesis of proteolysis targeting chimera linker variants | ||
| 909 | ‡a (orcid) 0000000165004107 ‡9 1 | ||
| 919 | ‡a challengingpietosplicedruggingthespliceosome ‡A A Challenging Pie to Splice: Drugging the Spliceosome. ‡9 1 | ||
| 919 | ‡a advanceofseriniquinoneanaloguesasmelanomaagents ‡A Advance of Seriniquinone Analogues as Melanoma Agents ‡9 1 | ||
| 919 | ‡a colorcodedsuperresolutionsmallmoleculeimaging ‡A Color-Coded Super-Resolution Small-Molecule Imaging ‡9 1 | ||
| 919 | ‡a covalentmodificationofbiologicaltargetswithnaturalproductsthroughpaalknorrpyrroleformation ‡A Covalent modification of biological targets with natural products through Paal-Knorr pyrrole formation. ‡9 1 | ||
| 919 | ‡a encodingmatterwithregiospecific12c13cisotopiclabels ‡A Encoding matter with regiospecific 12C/13C isotopic labels ‡9 1 | ||
| 919 | ‡a exploringthebenefitsofnanotechnologyforcancerdrugsindifferentstagesofthedrugdevelopmentpipeline ‡A Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline ‡9 1 | ||
| 919 | ‡a fluorescentmechanismbasedprobeforaerobicflavindependentenzymeactivity ‡A Fluorescent Mechanism-Based Probe for Aerobic Flavin-Dependent Enzyme Activity ‡9 1 | ||
| 919 | ‡a futuredirectionsofmarinemyxobacterialnaturalproductdiscoveryinferredfrommetagenomics ‡A Future Directions of Marine Myxobacterial Natural Product Discovery Inferred from Metagenomics ‡9 1 | ||
| 919 | ‡a metabolicandbiosyntheticdiversityinmarinemyxobacteria ‡A Metabolic and Biosynthetic Diversity in Marine Myxobacteria ‡9 1 | ||
| 919 | ‡a ritterostatingn1nacephalostatinritterazinebissteroidalpyrazinehybridselectivelytargetsgrp78 ‡A Ritterostatin GN 1N, a Cephalostatin-Ritterazine Bis-steroidal Pyrazine Hybrid, Selectively Targets GRP78. ‡9 1 | ||
| 919 | ‡a searchingforsmallmoleculeswithanatomicsort ‡A Searching for Small Molecules with an Atomic Sort ‡9 1 | ||
| 919 | ‡a tailoringchemoenzymaticoxidationviainsituperacids ‡A Tailoring chemoenzymatic oxidation via in situ peracids ‡9 1 | ||
| 919 | ‡a tracelessstaudingerligationenabledparallelsynthesisofproteolysistargetingchimeralinkervariants ‡A Traceless Staudinger ligation enabled parallel synthesis of proteolysis targeting chimera linker variants ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 CAOONL|ncf10306122 | ||
| 996 | ‡2 LC|no2012002386 | ||
| 996 | ‡2 LC|n 97000731 | ||
| 996 | ‡2 CAOONL|ncf10819326 | ||
| 996 | ‡2 LC|no2012129242 | ||
| 996 | ‡2 DNB|1066982597 | ||
| 996 | ‡2 ISNI|0000000398361148 | ||
| 996 | ‡2 LC|nr2004036515 | ||
| 996 | ‡2 ISNI|0000000042998105 | ||
| 996 | ‡2 J9U|987007321536705171 | ||
| 996 | ‡2 ISNI|0000000083214493 | ||
| 996 | ‡2 ISNI|0000000084425460 | ||
| 996 | ‡2 DNB|1055802355 | ||
| 996 | ‡2 ISNI|000000010965974X | ||
| 996 | ‡2 DNB|140334475 | ||
| 996 | ‡2 LC|n 2024061949 | ||
| 996 | ‡2 ISNI|0000000383315763 | ||
| 996 | ‡2 LC|no2006084568 | ||
| 996 | ‡2 LC|n 85828786 | ||
| 996 | ‡2 LC|no2006073268 | ||
| 996 | ‡2 DNB|1116973162 | ||
| 996 | ‡2 B2Q|0001270933 | ||
| 996 | ‡2 ISNI|000000006328091X | ||
| 996 | ‡2 NTA|067813135 | ||
| 996 | ‡2 ISNI|0000000054754319 | ||
| 996 | ‡2 ISNI|0000000055205215 | ||
| 996 | ‡2 LC|nb2022007605 | ||
| 996 | ‡2 LC|n 95052342 | ||
| 996 | ‡2 DNB|133951227 | ||
| 996 | ‡2 DNB|138709246 | ||
| 996 | ‡2 RERO|A003108750 | ||
| 996 | ‡2 ISNI|0000000034110743 | ||
| 996 | ‡2 SUDOC|183290127 | ||
| 996 | ‡2 LC|n 2002013342 | ||
| 996 | ‡2 SUDOC|183995945 | ||
| 996 | ‡2 NTA|131051067 | ||
| 996 | ‡2 PLWABN|9810629100305606 | ||
| 996 | ‡2 ISNI|000000002824514X | ||
| 996 | ‡2 LC|nr 93036868 | ||
| 996 | ‡2 LC|n 95081900 | ||
| 996 | ‡2 ISNI|0000000074001971 | ||
| 996 | ‡2 RERO|A024593323 | ||
| 996 | ‡2 ISNI|0000000031743721 | ||
| 996 | ‡2 CAOONL|ncf10571951 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
